Sanolla

Sanolla is a medical technology company founded in 2016 that specializes in AI-powered diagnostic solutions for primary care. The company focuses on the early detection and monitoring of chronic cardiopulmonary diseases, including heart failure, chronic obstructive pulmonary disease (COPD), and asthma. Sanolla is known for its innovative infrasound auscultation technology, which captures and analyzes body sounds, including inaudible frequencies, to enhance diagnosis and improve patient outcomes. The company's product lineup features the VoQX™ Smart Stethoscope, an FDA-cleared device that helps clinicians detect subtle sounds for better diagnosis. Another key product is PyXy™, a home monitoring device that utilizes AI and infrasound technology for early detection of exacerbations in chronic conditions, enabling remote patient monitoring. Sanolla also offers additional products that leverage their patented infrasound BOOST™ technology for real-time AI analysis. With ISO 13485 certification and several technology patents, Sanolla is committed to quality and innovation in the multibillion-dollar primary care diagnostic devices market. The leadership team includes experienced professionals dedicated to improving patient care and reducing healthcare costs globally.

• Employees 22
• Founded 2016
• Total Funding $5961330